Role of liposome in treatment of overactive bladder and interstitial cystitis
Intravesical (local) therapy of agents has been effective in delaying or preventing recurrence of superficial bladder cancer. This route of drug administration has also shown tremendous promise in the treatment of interstitial cystitis/painful bladder syndrome (IC/PBS) and overactive bladder without...
Main Authors: | Shih-Ya Hung, David D. Chancellor, Michael B. Chancellor, Yao-Chi Chuang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-03-01
|
Series: | Urological Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1879522614001225 |
Similar Items
-
Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction
by: Joseph J. Janicki, et al.
Published: (2016-03-01) -
Mechanisms Underlying Overactive Bladder and Interstitial Cystitis/Painful Bladder Syndrome
by: Luke Grundy, et al.
Published: (2018-12-01) -
Safety and dose flexibility clinical evaluation of intravesical liposome in patients with interstitial cystitis or painful bladder syndrome
by: Wei-Ching Lee, et al.
Published: (2011-10-01) -
Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
by: Jing-Liang Chen, et al.
Published: (2020-02-01) -
Adverse Events of Intravesical Onabotulinum Toxin A Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
by: Yuh-Chen Kuo, et al.
Published: (2016-03-01)